UPP1 and neoplasm: Whole-body genetic deletion of Upp1 did not influence the time to clinical endpoint (one primary tumour reaching 15 mm in diameter) (Fig. 6A), nor did it influence the final primary tumour burden of MMTV-PyMT mice (Fig. EV6A; Appendix Fig. S10A,B).